Market Research Report
Global Prenatal Testing and Newborn Screening Market 2016-2022
|Published by||BIS Research Inc.||Product code||351053|
|Published||Content info||150 Pages
Delivery time: 1-2 business days
|Global Prenatal Testing and Newborn Screening Market 2016-2022|
|Published: February 1, 2016||Content info: 150 Pages||
With the emergence of advanced technologies such as next generation sequencing, high throughput screening (HTS), and cell free fetal DNA, there has been a rise in the overall demand of the newly developed prenatal diagnosis and newborn screening tests. Presently, the main focus of the government initiatives is mainly towards developing non-invasive solutions, launching large number of newborn screening programs, controlling the increasing level of genetic disorders, and integrating advanced technologies to fulfill the unmet needs of the patients.
Governmental regulations and standards are playing a major role in sustaining the growth and development of the market. The main aim of these regulations is to make prenatal tests and solutions more adaptable and focused towards effective diagnosis of various genetic disorders & chromosomal abnormalities. The patients benefit indirectly through these regulations as it helps them save time and cuts-down the overall cost as the patients receive accurate and proper diagnosis & screening of the disease.
This study includes an overview and analysis of the prenatal and newborn genetic testing market, by type of tests, techniques, and geographical regions, allowing the research to develop a comprehensive outlook of the market. The prenatal and newborn genetic testing market report presents a detailed analysis of market dynamics and provides an extensive insight into various forms of developments, trends and key participants. All of the above mentioned report coverage parameters are discussed across different regions like The Americas, Europe, Asia Pacific (APAC), and Rest of the World (ROW).
The answers to the following key questions can be found in the report:
While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section of the prominent consortiums, compliances, and regulatory bodies, as well as their involvement in the prenatal and newborn genetic testing market. The research incorporates Porter's Five Force Model for an in-depth analysis of the prenatal and newborn genetic testing market and an assessment of the factors governing it. The analysis builds on a well-compiled value chain giving a detailed understanding of the ecosystem players and their market penetration.
The report includes the profiles of major players in the prenatal testing and newborn screening market that allows the readers to gain an insight into the various industry trends.
Prenatal Testing and Newborn Screening is one of the most modernized trends in the healthcare industry which has shown a tremendous level of progress in the last few years. The growth of prenatal and newborn genetic testing market is attributed primarily to a rapid increase in genetic disorders/abnormalities, increase in fetal mortality, and advancement of healthcare technologies. The global prenatal and newborn genetic testing market has a high growth potential in future and will grow over $10.63 billion by the end of forecast period. With the emergence of advanced technologies such as next generation sequencing, high throughput screening, and cell free fetal DNA, there has been a gradual rise in the overall demand of the newly developed prenatal diagnosis and newborn screening tests.
Factors such as legal approval of the prenatal testing and newborn screening in most of the states of the U.S. government investment & regulations, and healthcare policies of other developed and emerging countries are contributing to the overall market growth.
The report has been further classified into prenatal testing and newborn screening. Prenatal testing further segmented on the basis of techniques (diagnostic & screening) and nature of the test (invasive & non-invasive). Prenatal testing is dominating the market and growing at a CAGR of 27.98% from 2016 to 2022.
Diagnosis technologies are holding the maximum market share and are expected to grow at 26.54% CAGR from 2016 to 2022. The techniques can either be invasive and non-invasive. By studying the current trends, it can be said that non-invasive prenatal testing are gaining more traction from the patients. Lifestyle preferences such as smoking, drinking, obesity, increasing maternity age, and genetic disorders are some of the factors responsible for the growth of the market.
North America is the largest contributor in the overall revenue generation in prenatal and newborn care, followed by the European region, and is expected to grow at a CAGR of 23.36% from 2016 to 2022. While the U.S., the U.K., Japan, and India show a dynamic growth in the overall market due to an increasing prevalence of genetic disorders in these countries. Moreover, APAC region is focusing more on technological developments and introduction of new advanced tools in the field of prenatal and newborn care in order to develop specific tests and solutions.
North America, Europe, APAC, ROW (Middle East, Africa & South America)